AIG
BLCM

American International Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

American International Group’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,568
Closed -$87K – 3178
2019
Q1 		$87K Sell
2,568
-84
-3% -$2.81K ﹤0.01% 2687
2018
Q4 		$77K Sell
2,652
-20
-0.7% -$887 ﹤0.01% 2724
2018
Q3 		$165K Buy
2,672
+77
+3% +$5.21K ﹤0.01% 2548
2018
Q2 		$192K Buy
2,595
+858
+49% +$66.9K ﹤0.01% 2376
2018
Q1 		$114K Sell
1,737
-93
-5% -$7.02K ﹤0.01% 2591
2017
Q4 		$154K Buy
1,830
+8
+0.4% +$785 ﹤0.01% 2478
2017
Q3 		$210K Buy
1,822
+137
+8% +$14.4K ﹤0.01% 2265
2017
Q2 		$197K Buy
1,685
+395
+31% +$49K ﹤0.01% 2275
2017
Q1 		$159K Buy
1,290
+85
+7% +$11.1K ﹤0.01% 2332
2016
Q4 		$164K Sell
1,205
-3
-0.2% -$533 ﹤0.01% 2315
2016
Q3 		$240K Buy
1,208
+2
+0.2% +$344 ﹤0.01% 2046
2016
Q2 		$156K Buy
1,206
+622
+107% +$69.2K ﹤0.01% 2311
2016
Q1 		$54K Hold
584
– – ﹤0.01% 3845
2015
Q4 		$118K Sell
584
-1
-0.2% -$179 ﹤0.01% 3355
2015
Q3 		$85K Hold
585
– – ﹤0.01% 3604
2015
Q2 		$124K Buy
585
+485
+485% +$119K ﹤0.01% 3483
2015
Q1 		$23.2K Hold
100
– – ﹤0.01% 4291
2014
Q4 		$23K Buy
+100
New +$21.4K ﹤0.01% 4274

Other funds holding BLCM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American International Group's BLCM Position: Q2 2019 in Review

American International Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2019, closing a stake of 2,568 shares — an estimated $87K sold.

American International Group first reported a position in BLCM in Q4 2014 and held it in 18 quarters. The position peaked at $240K in Q3 2016. 79 funds tracked by Wall St. Rank hold BLCM as of Q2 2019.

  • American International Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • American International Group sold 2,568 Bellicum Pharmaceuticals, Inc. shares in Q2 2019, an estimated $87K.
  • American International Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 18 quarters.
  • American International Group's Bellicum Pharmaceuticals, Inc. position peaked at $240K in Q3 2016.
  • 79 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.